Urine Collector Market Report 2025

The urine collector market size has grown strongly in recent years. It will grow from $1.19 billion in 2024 to $1.31 billion in 2025 at a compound annual growth rate (CAGR) of 9.9%. The growth during the historic period was driven by the rising prevalence of urinary tract infections, increasing rates of diabetes, expansion of the geriatric population, growing hospital admissions, and higher prevalence of urinary incontinence.

The urine collector market size is expected to see strong growth in the next few years. It will grow to $1.89 billion in 2029 at a compound annual growth rate (CAGR) of 9.5%. The growth during the forecast period is fueled by increasing preference for home based healthcare, rising prevalence of chronic diseases, growing demand for customized urine collection systems, expanding focus on improving healthcare infrastructure, and greater emphasis on early diagnosis of chronic conditions. The primary trends in the forecast period include advancements in medical devices, improvements in silicone formulations, technological innovations in urine collection and analysis, integration of point-of-care testing formats, and development of automated instruments to enhance efficiency.

The increasing prevalence of chronic kidney disease is expected to drive the growth of the urine collector market. Chronic kidney disease (CKD) is a progressive condition where the kidneys gradually lose their ability to filter blood effectively. The rise in CKD cases is largely due to the aging population, as kidney function naturally declines with age, and older adults are more prone to diabetes and hypertension - two leading causes of kidney damage. Urine collectors are vital tools in managing CKD, enabling healthcare providers to collect accurate urine samples for tests such as the albumin-to-creatinine ratio (UACR) and protein-to-creatinine ratio (UPCR), which monitor kidney function and disease progression. For example, the Australian Institute of Health and Welfare reported in June 2024 that CKD mortality rates increased by 4.2% in 2021 and by 6.2% in 2022, with CKD contributing to approximately 22,000 deaths in 2022, accounting for 11% of all deaths in Australia. This growing burden of chronic kidney disease is boosting the demand for urine collectors.

Companies in the urine collector market are focusing on innovative solutions such as gender-specific external collection systems to improve comfort, safety, and overall quality of life for patients. These systems are designed to align with male and female anatomy, improving fit, comfort, and effectiveness, while minimizing leakage and reducing the risk of infection. This approach enhances dignity, discretion, and user compliance. For example, in July 2024, Mexple, an India-based medical equipment manufacturer, launched UroMen and UroWomen urine collection kits, specifically tailored for men and women. These kits are made from medical-grade materials, incorporate backflow prevention technology, and are reusable, making them suitable for various care settings such as homes, hospitals, nursing facilities, and post-surgical recovery. The products reduce skin contact with urine, minimizing irritation, infection risk, and odor, and provide greater mobility and discretion compared to traditional adult diapers or indwelling catheters. This product launch reflects a broader trend in the industry toward patient-centered designs that prioritize both functionality and comfort.

In September 2024, PreAnalytix GmbH, a Switzerland-based manufacturer of urine collection devices, partnered with QIAGEN N.V. and Becton, Dickinson and Company (BD) to develop a standardized urine liquid biopsy solution for non-invasive cell-free DNA analysis. The collaboration aims to provide researchers and clinicians with a reliable, standardized, and easy-to-use method for urine sample collection, stabilization, and genomic analysis, advancing diagnostic and therapeutic research. QIAGEN, based in the Netherlands, specializes in molecular diagnostics and sample preparation technologies, while BD, a US-based medical technology company, focuses on medical devices, laboratory instruments, and diagnostic products.

Major players in the urine collector market are Cardinal Health Inc., F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Medline Industries LP, Stryker Corporation, Becton Dickinson and Company, B. Braun Melsungen Aktiengesellschaft, Coloplast A/S, Teleflex Incorporated, ConvaTec Group PLC, Integra LifeSciences Holdings Corporation, Hollister Incorporated, Amsino International Inc., Polymed Medical Devices, Sterimed Group, Labcon North America Inc., Romsons Scientific & Surgical Pvt. Ltd., FL Medical srl, and China National Wholesales Trading Corporation.

North America was the largest region in the urine collector market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in urine collector report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the urine collector market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

A urine collector is a medical device designed to safely and hygienically gather and store urine for purposes such as testing, monitoring, or treatment. It is engineered to maintain cleanliness and accuracy while preventing sample contamination. The device is available in various forms, including bags, cups, or specialized containers, depending on the specific application.

The primary types of urine collectors are urinals, bottle urine collectors, bag urine collectors, and catheter urine collectors. A urinal is an affordable, bottle shaped device with measurement markings, designed to allow bedridden patients to collect urine conveniently and accurately. These devices are made from materials such as plastic, silicone, and glass, with capacities ranging from 100-250 milliliters, 250-500 milliliters, 500-1000 milliliters, and above 1000 milliliters. They can be single-use or reusable and are used by hospitals and clinics, nursing homes and assisted living facilities, and home healthcare settings.

The urine collector market research report is one of a series of new reports that provides urine collector market statistics, including urine collector industry global market size, regional shares, competitors with the urine collector market share, urine collector market segments, market trends, and opportunities, and any further data you may need to thrive in the urine collector industry. This urine collector market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The urine collector market consists of sales of urine collection bags, catheter drainage bags, leg bags, urine bottles, external condom catheters with collection bags, and urine collection pouches. Values in this market are ‘factory gate’ values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.